Gilde’s Latest Venture Fund Guided By Health Care Cost-Cutting
This article was originally published in The Pink Sheet Daily
Executive Summary
The European VC closed a €145 million ($200 million) transatlantic growth fund to capitalize on health care advancements that provide better care at lower cost.